It is thus not surprising that the focus of the pharmacological study on phytochemicals for the treatment of depression has been targeting neurotrophic factors, among which BDNF, GDNF, VEGF, and NGF are the most relevant neurotrophins. This evidence concerns the gene NGF and depressive symptom measurement.